JP7109092B2 - リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤 - Google Patents

リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤 Download PDF

Info

Publication number
JP7109092B2
JP7109092B2 JP2019541220A JP2019541220A JP7109092B2 JP 7109092 B2 JP7109092 B2 JP 7109092B2 JP 2019541220 A JP2019541220 A JP 2019541220A JP 2019541220 A JP2019541220 A JP 2019541220A JP 7109092 B2 JP7109092 B2 JP 7109092B2
Authority
JP
Japan
Prior art keywords
pain
lidocaine
diclofenac
skin
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019541220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020505416A5 (enExample
JP2020505416A (ja
Inventor
アントニオ・ナルディ
クラウス・シーネ
トーマス・クリストフ
ゼバスティアン・ヴァハテン
イルムガルト・ベスル
アンドレアス・ショルツ
インゴ・フリードリヒ
ゼバスティアン・ウルリヒ
ジモーネ・ケーニヒ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teikoku Seiyaku Co Ltd
Original Assignee
Teikoku Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co Ltd filed Critical Teikoku Seiyaku Co Ltd
Publication of JP2020505416A publication Critical patent/JP2020505416A/ja
Publication of JP2020505416A5 publication Critical patent/JP2020505416A5/ja
Application granted granted Critical
Publication of JP7109092B2 publication Critical patent/JP7109092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2019541220A 2017-01-31 2018-01-29 リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤 Active JP7109092B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17154009 2017-01-31
EP17154009.9 2017-01-31
PCT/EP2018/052031 WO2018141661A1 (en) 2017-01-31 2018-01-29 Pharmaceutical patch comprising lidocaine and diclofenac for treating neuropathic pain

Publications (3)

Publication Number Publication Date
JP2020505416A JP2020505416A (ja) 2020-02-20
JP2020505416A5 JP2020505416A5 (enExample) 2021-03-11
JP7109092B2 true JP7109092B2 (ja) 2022-07-29

Family

ID=57963027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019541220A Active JP7109092B2 (ja) 2017-01-31 2018-01-29 リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤

Country Status (3)

Country Link
US (1) US20190388360A1 (enExample)
JP (1) JP7109092B2 (enExample)
WO (1) WO2018141661A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7069042B2 (ja) 2016-12-28 2022-05-17 久光製薬株式会社 貼付剤
EP4054549A4 (en) * 2019-11-06 2023-12-06 Smartech Topical, Inc. TOPICAL FORMULATIONS OF CYCLO-OXYGENASE INHIBITORS AND THEIR USE
JP6744511B1 (ja) * 2020-02-12 2020-08-19 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
EP4248953A4 (en) * 2020-11-20 2024-05-22 Sailing Pharmaceutical Technology Group Co., Ltd. BRUCIGEL PLASTER AND PRODUCTION METHOD AND USE THEREOF
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
JP2004323502A (ja) 2002-08-02 2004-11-18 Medorekkusu:Kk 浸透拡散性に優れた消炎鎮痛外用剤
JP2005068035A (ja) 2003-08-20 2005-03-17 Medorekkusu:Kk 慢性疼痛治療用外用剤
JP2005145931A (ja) 2003-11-19 2005-06-09 Medorekkusu:Kk 非ステロイド系消炎鎮痛剤を含有するテープ剤
JP2005145930A (ja) 2003-11-19 2005-06-09 Medorekkusu:Kk 非ステロイド系消炎鎮痛剤を含む消炎鎮痛外用剤および組成物の製造方法
CN101530401A (zh) 2008-03-12 2009-09-16 中山市中健药物研究所有限公司 一种用于治疗急慢性炎性疼痛的复方透皮贴片
JP2013501051A (ja) 2009-08-06 2013-01-10 株式会社エービーサイズ ナノ粒子の溶液およびナノ粒子の懸濁物の両者を有する局所用薬学的調製物ならびに該調製物をもって急性疼痛および慢性疼痛を処置する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166641B2 (en) 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
DE102004001093A1 (de) 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
WO2011005853A2 (en) 2009-07-08 2011-01-13 Msk Pharma, Llc Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
JP2004323502A (ja) 2002-08-02 2004-11-18 Medorekkusu:Kk 浸透拡散性に優れた消炎鎮痛外用剤
JP2005068035A (ja) 2003-08-20 2005-03-17 Medorekkusu:Kk 慢性疼痛治療用外用剤
JP2005145931A (ja) 2003-11-19 2005-06-09 Medorekkusu:Kk 非ステロイド系消炎鎮痛剤を含有するテープ剤
JP2005145930A (ja) 2003-11-19 2005-06-09 Medorekkusu:Kk 非ステロイド系消炎鎮痛剤を含む消炎鎮痛外用剤および組成物の製造方法
CN101530401A (zh) 2008-03-12 2009-09-16 中山市中健药物研究所有限公司 一种用于治疗急慢性炎性疼痛的复方透皮贴片
JP2013501051A (ja) 2009-08-06 2013-01-10 株式会社エービーサイズ ナノ粒子の溶液およびナノ粒子の懸濁物の両者を有する局所用薬学的調製物ならびに該調製物をもって急性疼痛および慢性疼痛を処置する方法

Also Published As

Publication number Publication date
US20190388360A1 (en) 2019-12-26
WO2018141661A1 (en) 2018-08-09
JP2020505416A (ja) 2020-02-20

Similar Documents

Publication Publication Date Title
JP7109092B2 (ja) リドカインおよびジクロフェナクを含む神経障害性疼痛の治療用の医薬用貼付剤
EP2809307B1 (en) Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
EP2557924B1 (en) Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
KR101891186B1 (ko) 덱스메데토미딘 경피 조성물을 포함하는 통증을 관리하기 위한 방법 및 조성물
EP1844773A1 (en) Percutaneous absorption preparation
KR20190060007A (ko) 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
JP2022087276A (ja) メマンチン経皮送達システム
JP2010530902A (ja) 流涎症治療のためのグリコピロレートを含む経皮送達システム
JP7109093B2 (ja) リドカインおよびジクロフェナクを含む医薬用貼付剤についての投与計画
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
JP2020500915A (ja) 末梢神経障害性疼痛の治療に使用するための局所作用用フェニトイン
US20170128388A1 (en) Pharmaceutical Patch for Transdermal Administration of Tapentadol
EP1652523A1 (en) Transdermal absorption preparation
JP2023521563A (ja) ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム
AU2016259348B9 (en) Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use
JP7716111B2 (ja) 神経変性疾患の症状の緩和又は治療のための貼付剤
ES2447829T3 (es) Combinación para el tratamiento de la osteoartritis
CN101180018B (zh) 用于治疗恶心的经皮的方法和贴片
US9687549B2 (en) Topical pharmaceutical gel composition of diclofenac sodium
JP2002097134A (ja) オキセサゼインを有効成分とする皮膚外用剤
US20160263065A1 (en) Topical pharmaceutical gel composition of diclofenac sodium
JP2024512791A (ja) ニフェジピンとリドカインとを含む局所用ワイプ
JP2017122071A (ja) ケロイド・肥厚性瘢痕形成抑制及び治癒促進のための経皮吸収製剤
AU2014274532A1 (en) Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use
HK1243630B (zh) 1-甲基-n-(2，6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220531

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220614

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220711

R150 Certificate of patent or registration of utility model

Ref document number: 7109092

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250